In a regulatory filing, Ken Myszkowski notified Arrowhead (ARWR) of his decision to retire as CFO of the company, effective as of May 13.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced that its Chief Financial Officer, Ken Myszkowski, is set to retire on May 13, 2025, marking the end of his 16-year tenure with the company.

Arrowhead Pharmaceuticals ... Daniel Apel will step into the CFO role, bringing with him substantial financial experience from his previous positions at Walgreens Boots Alliance and Bayer.